대성미생물

036480KOSDAQ

42.0 / 100

Reference Date: 2026-09-09

Financial Score14.5 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly down 1.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Daesung Microbiological is a specialized animal pharmaceutical company founded in 1966, producing and selling over 150 types of products including vaccines, antibiotics, and nutritional supplements. Its revenue is composed of 72% domestic sales and 28% exports, with a growing export share. The company continuously develops new products through R&D aligned with disease trends.

Number of Employees

138people

Average Salary

44.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

39.24Industry Average 15.000.0Point

2.6x industry avg (risky)

PBR

—Industry Average 1.203.5Point

ROE

1.70Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

39.60Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.1% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲10.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.6% (improving, 2yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
“세계 3위 동물약품시장을 잡아라”…동물약품협회, ‘브라질 시장개...
The news focuses on broader industry participation in a livestock exhibition rather than direct impact on 대성미생물's stock.

Detailed Momentum

52-week position1.0Point

Near 52w low (13%, downtrend)

Current 6,160Won52-week high 9,88052-week low 5,590

1-month return3.0Point

1m -1.12% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14